We found that the prior enrichment of CCR6+Tregs but not CCR6−Tregs in tumor mass during progression of murine breast cancer, which was dependent on the dominant proliferation of CCR6+ Tregs in situ. This evidence concerns the gene CCR6 and neoplasm.